Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Here's What to Expect From Amgen’s Next Earnings Report

With a market cap of $158.6 billion, Amgen Inc. (AMGN) is a leading global biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics for serious illnesses, with a strong emphasis on oncology, nephrology, cardiovascular disease, and inflammation.

The company is expected to release its fiscal Q3 2025 earnings results after the market closes on Tuesday, Nov. 4. Ahead of this event, analysts expect AMGN to report a profit of $5.01 per share, down 10.2% from $5.58 per share in the prior year's quarter. It has consistently surpassed Wall Street's bottom-line estimates in the past four quarters. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.